Tema Healthcare AI 

$29.59
38
-$0.11-0.36% Friday 20:00
+$0.00+0%Friday 20:00After hours

Statistics

Day High
29.58
Day Low
29.58
52W High
31.22
52W Low
24.88
Volume
300
Avg. Volume
-
Mkt Cap
4.69B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Expense Ratio

0.75%
0%
1%+
The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.

Dividends

0%Dividend Yield
Jan 9
$0.05
Dec 8
$0.05
Nov 8
$0.05
Oct 8
$0.05
Sep 8
$0.09
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

23AugExpected
Q3 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
-0.54
-0.36
-0.18
0
Expected EPS
-0.19
Actual EPS
N/A

Financials

-526.48%Profit Margin
Unprofitable
2020
2021
2022
2023
70.94MRevenue
-373.46MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HLTH. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap177.55B
Abbott Laboratories offers a range of diagnostics products, including rapid diagnostics solutions, directly competing with Cue Health's diagnostic offerings.
Thermo Fisher Scientific
TMO
Mkt Cap240.87B
Thermo Fisher Scientific provides analytical instruments, reagents and consumables, and software services, competing in the diagnostics and healthcare solutions space.
Quest Diagnostics
DGX
Mkt Cap27.2B
Quest Diagnostics is a provider of diagnostic information services, directly competing with Cue Health in the diagnostics and healthcare information market.
Labcorp
LH
Mkt Cap22.7B
Laboratory Corporation of America Holdings operates as a life sciences company and a direct competitor in the clinical laboratory services market.
Bio-Rad Laboratories
BIO
Mkt Cap10.06B
Bio-Rad Laboratories manufactures and supplies products and systems used for the life science research and clinical diagnostics markets, competing with Cue Health's diagnostic technologies.
QuidelOrtho
QDEL
Mkt Cap728.27M
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions, including rapid diagnostic testing, a direct competition to Cue Health's offerings.
Dexcom
DXCM
Mkt Cap33.72B
DexCom, Inc. focuses on the design and development of continuous glucose monitoring systems, competing in the broader health monitoring and diagnostics market.
Baxter International
BAX
Mkt Cap11.79B
Baxter International Inc. provides a portfolio of healthcare products, including hospital and renal products, competing in the healthcare solutions space.
Medtronic
MDT
Mkt Cap117.85B
Medtronic plc specializes in medical technologies, services, and solutions, competing in the healthcare and diagnostics market with a broad portfolio that can overlap with Cue Health's market.

Holdings

Regions

Sectors

About

Health Services
Hospital/Nursing Management
Cue Health Inc. functioned as a healthcare technology company, developing the Cue Health platform to provide individuals and healthcare providers with convenient and personalized access to lab-quality diagnostic tests, usable both at home and at the point-of-care. The platform also enabled on-demand telehealth consultations and offered treatment options for various health and wellness needs. Its core offering, the Cue Integrated Care platform, comprised essential hardware components like the Cue Health Monitoring System (featuring a reusable Cue Reader, a single-use Cue Cartridge, and a Cue Wand), sophisticated software including the cloud-based Cue Data and Innovation Layer for analytics, and virtual care delivery applications such as the Cue Health App and Cue Enterprise Dashboard. The platform also integrated with a broader ecosystem, connecting to electronic medical record systems, pharmacies, last-mile delivery services, clinician networks, and laboratories. Additionally, the company supplied COVID-19 testing kits. Founded in 2010 in San Diego, California, the firm was formerly known as Cue Inc. until its name change in December 2017. However, on May 28, 2024, Cue Health Inc. and its affiliates initiated voluntary liquidation by filing for Chapter 7 bankruptcy in the U.S. Bankruptcy Court for the District of Delaware.
Show more...
CEO
Clint Sever
Employees
726
Country
United States
ISIN
US87975E7682

Listings

0 Comments

Share your thoughts

FAQ

What is Tema Healthcare AI stock price today?▼
The current price of HLTH is $29.59 USD — it has decreased by -0.36% in the past 24 hours. Watch Tema Healthcare AI stock price performance more closely on the chart.
What is Tema Healthcare AI stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Tema Healthcare AI stocks are traded under the ticker HLTH.
What is Tema Healthcare AI market cap?▼
Today Tema Healthcare AI has the market capitalization of 4.69B
What is Tema Healthcare AI revenue for the last year?▼
Tema Healthcare AI revenue for the last year amounts to 70.94M USD.
What is Tema Healthcare AI net income for the last year?▼
HLTH net income for the last year is -373.46M USD.
Does Tema Healthcare AI pay dividends?▼
Yes, HLTH dividends are paid monthly. The last dividend per share was 0.05 . As of today, Dividend Yield (FWD)% is 0%.
How many employees does Tema Healthcare AI have?▼
As of September 26, 2026, the company has 726 employees.
In which sector is Tema Healthcare AI located?▼
Tema Healthcare AI operates in the Health & Wellness sector.
When did Tema Healthcare AI complete a stock split?▼
Tema Healthcare AI has not had any recent stock splits.
Where is Tema Healthcare AI headquartered?▼
Tema Healthcare AI is headquartered in San Diego, United States.